Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...

TimesSquare Capital U.S. Mid Cap Growth Strategy highlighted stocks like Cencora, Inc. (NYSE:COR), in the third quarter 2024 investor letter. Cencora, Inc. (NYSE:COR) sources and distributes ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 (Buy) ...

Cencora (COR ... detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth. Over the last quarter, the company's share price increased ...

BofA analyst Allen Lutz raised the firm’s price target on Cencora (COR) to $285 from $270 and keeps a Neutral rating on the shares. The recent ...

Cencora COR has outperformed the market over ... note how much of a difference compounded returns can make in your cash growth over a period of time.

Cencora, Inc. COR is well-poised for growth on the back of robust U.S ... This acquisition complements COR’s pharmaceutical-centric strategy, strengthens its Management Services Organization ...